Design, Synthesis, and Evaluation of Doxifluridine Derivatives as Nitroreductase-Responsive Anticancer Prodrugs
Molecules · 2024
DOI: 10.3390/molecules29215077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Xinmeng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Macromolecular Drug Development and Manufacturing, School of Pharmaceutical Sciences and Food Engineering, Liaocheng Unive…. Hauptthemen laut MEDLINE: Prodrugs, Floxuridine, Nitroreductases, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Project of Research and Development of Shandong Province, National Natural Science Foundation of China, "Youth Innovation Team Plan" of Shandong Province Higher Education.
Abstract (Originalsprache)
Antimetabolite antitumor drugs interfere with nucleic acid and DNA synthesis, causing cancer cell death. However, they also affect rapidly dividing normal cells and cause serious side effects. Doxifluridine (5′-deoxy-5-fluorouridine [5′-DFUR]), a 5-fluorouracil (5-FU) prodrug converted to 5-FU by thymidine phosphorylase (TP), exerts antitumor effects. Since TP is distributed in tumor and normal tissues, 5′-DFUR features side effects. Here we designed a series of novel 5′-DFUR derivatives based on high nitroreductase (NTR) levels in the hypoxic microenvironment of tumor tissues by introducing nitro-containing moieties into the 5′-DFUR structure. These derivatives exert their antitumor effects by producing 5-FU under the dual action of TP and NTR in the tumor microenvironment. The derivatives were synthesized and their stability, release, and cytotoxicity evaluated in vitro and antitumor activity evaluated in vivo. Compound 2c, featuring nitrofuran fragments, was stable in phosphate-buffered saline and plasma at different pH values and reduced rapidly in the presence of NTR. The in vitro cytotoxicity evaluation indicated that compound 2c showed excellent selectivity in the MCF-7 and HT29 cell lines. Moreover, it exhibited antitumor effects comparable to those of 5′-DFUR in vivo without significant toxic side effects. These results suggest that compound 2c is a promising antitumor prodrug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Macromolecular Drug Development and Manufacturing, School of Pharmaceutical Sciences and Food Engineering, Liaocheng University, 1 Hunan Street, Liaocheng 252059, China.
ORCID-Profile: Xuekun Wang
Förderung
- Major Project of Research and Development of Shandong Province
- National Natural Science Foundation of China
- "Youth Innovation Team Plan" of Shandong Province Higher Education
- Guangyue Young Scholar Innovation Team of Liaocheng University
- “Youth Innovation Team Plan” of Shandong Province Higher Education
Zitieren
APA
Zhang, X., Dong, T., Li, X., Xu, C., Chen, F., Wang, S., & Wang, X. (2024). Design, Synthesis, and Evaluation of Doxifluridine Derivatives as Nitroreductase-Responsive Anticancer Prodrugs. Molecules. https://doi.org/10.3390/molecules29215077
Vancouver
Zhang X, Dong T, Li X, Xu C, Chen F, Wang S, et al. Design, Synthesis, and Evaluation of Doxifluridine Derivatives as Nitroreductase-Responsive Anticancer Prodrugs. Molecules. 2024. doi:10.3390/molecules29215077
BibTeX
@article{Zhang2024,
author = {Zhang, Xinmeng and Dong, Taimin and Li, Xu and Xu, Changjie and Chen, Fanghui and Wang, Shiben and Wang, Xuekun},
title = {Design, Synthesis, and Evaluation of Doxifluridine Derivatives as Nitroreductase-Responsive Anticancer Prodrugs},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29215077}
}
EUVIMED